Corpus callosum agenesis neuronopathy
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
3
|
41
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2008 |
Stimulant abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
3
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Aplasia cutis congenita over the scalp vertex
|
disease |
|
Congenital Abnormality
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Moderate pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Congenital localized absence of skin
|
disease |
|
Congenital Abnormality
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Hidrotic Ectodermal Dysplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
8
|
7
|
0.300 |
None |
|
0 |
|
|
|
Adenoid cystic breast carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Skin appendage adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ablepharon
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
20
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diseases of mitral valve
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
21
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Dysphoric mood
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
22
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Abnormality of bone mineral density
|
disease |
|
Anatomical Abnormality
|
22
|
1
|
0.100 |
None |
|
0 |
|
|
|
Calvarial skull defect
|
disease |
|
Anatomical Abnormality
|
22
|
|
0.100 |
None |
|
0 |
|
|
|
Polymorphous low grade adenocarcinoma
|
disease |
|
Neoplastic Process
|
23
|
1
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Treatment-resistant schizophrenia
|
disease |
|
Mental or Behavioral Dysfunction
|
23
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE
|
disease |
|
Disease or Syndrome
|
25
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
25
|
35
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anhydrotic Ectodermal Dysplasias
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
29
|
2
|
0.300 |
None |
|
0 |
|
|
|
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A
|
disease |
|
Disease or Syndrome
|
34
|
3
|
0.020 |
None |
1.000 |
2 |
|
1995 |
1997 |
Prolonged bleeding time
|
phenotype |
|
Finding
|
39
|
3
|
0.100 |
None |
|
0 |
|
|
|
Prehypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
41
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Triploidy syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Central Core Myopathy (disorder)
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
44
|
110
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Christ-Siemens-Touraine syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
45
|
78
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Arteriosclerotic cardiovascular disease, NOS
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
58
|
5
|
0.060 |
None |
1.000 |
6 |
|
2017 |
2019 |